Quintiles Transnational, the world's largest CRO and provider of commercial outsourcing services to biopharmas, raised $947 million by offering 23.7 million shares (45% insider) at $40, the high end of the range of $36 to $40. Insider shares represented 100% of the increase in the number of shares offered. Quintiles Transnational plans to list on the NYSE under the symbol "Q". Morgan Stanley, Barclays and J.P. Morgan acted as lead managers on the deal.
